Genetic engineering of Lactococcus lactis to produce an amylase inhibitor for development of an anti-diabetes biodrug. [electronic resource]
Producer: 20120416Description: 35-42 p. digitalISSN:- 1121-7138
- Amylases -- antagonists & inhibitors
- Animals
- Biological Products -- metabolism
- Blood Glucose -- analysis
- Cloning, Molecular
- Diabetes Mellitus, Experimental -- diet therapy
- Enzyme Inhibitors -- metabolism
- Gene Expression Regulation, Bacterial
- Genetic Engineering
- Genetic Vectors -- genetics
- Hypoglycemic Agents -- metabolism
- Lactococcus lactis -- genetics
- Male
- Mice
- Mice, Inbred C57BL
- Oligopeptides -- genetics
- Transformation, Bacterial
- Treatment Outcome
- Yogurt -- microbiology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.